Cancer and Leukemia Group B (CALGB) Research Base — Chicago, Illinois

Cancer and Leukemia Group B (CALGB) Research Base is a clinical research site located in Chicago, Illinois, United States 60604-1104.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Cancer and Leukemia Group B (CALGB) Research Base has participated in 2 clinical trials.

Therapeutic areas: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma.

Sponsors: National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

• The University of Chicago Medicine Duchossois Center for Advanced Medicine
• Jeffrey Kramer, MDSC at Mercy Hospital
• University Consultants in Allergry and Immunology
• Rush University Med Ctr
• University of Illinois Medical Center in Chicago
• University of Chicago Medical Center (UCMC) Center for Advanced Medicine (CAM)
• Rush University Medical Center-Orthopedic Spine
• Northestern University
• University of Chicao
• Rush University Medical Center - Department Of Cardiology
• Northwestern University Diagnostic Testing Center
• University of Illinois Chicago

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer and Leukemia Group B (CALGB) Research Base?

Cancer and Leukemia Group B (CALGB) Research Base has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer and Leukemia Group B (CALGB) Research Base conducted?

Cancer and Leukemia Group B (CALGB) Research Base has 2 clinical trials on record. Their work covers Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma.

Is Cancer and Leukemia Group B (CALGB) Research Base accredited by Crixeo Clinical Trials?

Cancer and Leukemia Group B (CALGB) Research Base has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer and Leukemia Group B (CALGB) Research Base?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.